BCL2L2 and Alzheimer disease: Increased expression of BCL2L2 is associated with neurofibrillary tangle pathology in AD [182], and it promotes the expression of senescence-associated beta-galactosidase, p53, p21, and p16 which are all hallmark features of cellular senescence [24, 54].